PRTA Prothena Corporation plc

54.89
+1  (2%)
Previous Close 54.08
Open 54.57
Price To book 5.14
Market Cap 1.92B
Shares 35,028,000
Volume 269,428
Short Ratio 16.79
Av. Daily Volume 306,571

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 planned for 2017.
PRX002
Parkinson's disease
Phase 1b data due 3Q 2017.
PRX003
Psoriatic Arthritis
Phase 3 enrollment to be completed by 2Q 2017.
NEOD001 VITAL
AL Amyloidosis
Phase 2b data due 2Q 2018.
NEOD001 PRONTO
Previously-treated patients with AL amyloidosis and persistent cardiac dysfunction

Latest News

  1. Prothena Corp. Plc – Value Analysis (NASDAQ:PRTA) : April 24, 2017
  2. Prothena Corp. Plc breached its 50 day moving average in a Bullish Manner : PRTA-US : April 21, 2017
  3. Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : April 6, 2017
  4. Prothena Corporation plc : Press Release
  5. Clinical Results Presented from Prothena’s Phase 1b Study of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration and Significant Reduction of Free Serum Alpha-synuclein in Patients with Parkinson’s Disease
  6. Don't Let Offerings Blindside Your Thesis
  7. Why Is Prothena (PRTA) Up 4.5% Since the Last Earnings Report?
  8. Results for Prothena's Phase 1b Multiple Ascending Dose Study of PRX002...
  9. Results for Prothena’s Phase 1b Multiple Ascending Dose Study of PRX002/RG7935 in Patients with Parkinson’s Disease to be Presented at the 13th​ International Conference on Alzheimer's and Parkinson's Diseases
  10. Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market
  11. Prothena Announces Pricing of Public Offering of 2,700,000 Ordinary Shares
  12. Prothena Corporation plc : Prothena Announces Public Offering of Ordinary Shares
  13. Prothena Announces Public Offering of Ordinary Shares
  14. Prothena Corp. Plc :PRTA-US: Earnings Analysis: 2016 By the Numbers : February 17, 2017
  15. Prothena (PRTA) Reports Wider-than-Expected Loss in Q4
  16. Edited Transcript of PRTA earnings conference call or presentation 14-Feb-17 9:30pm GMT
  17. Prothena reports 4Q loss
  18. Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update